For most medicines in Britain, there is one obvious door: a GP appointment, a prescription and a trip to the chemist. Mounjaro, the weekly weight-management injection containing tirzepatide, is unusual in that two distinct doors have opened at once. One leads through the NHS, where access is being introduced in phases according to clinical criteria. The other leads through private, regulated online pharmacies, where eligible adults complete a consultation and pay for the medicine themselves. This feature sets out how the two routes differ, and, just as importantly, what stays exactly the same whichever door a patient uses.
Two doors to the same medicine
It helps to start with what does not change. Mounjaro is a prescription-only medicine, licensed by the UK medicines regulator and supplied as a pre-filled KwikPen. Whether a patient receives it on the NHS or privately, it is the same product, held under the same cold-chain requirements, with the same patient information leaflet and the same list of possible side effects. No route makes it available without a prescriber’s decision, and no legitimate route involves a pharmacist being absent from the process.
What differs is who assesses the patient, how long that takes, who pays and how the ongoing relationship works. Those differences are significant enough that many people are weighing them carefully before deciding which route suits their circumstances.
The NHS route: phased, criteria-based and specialist-led
The NHS has approached weight-management injections cautiously and deliberately. Rather than making the medicine available to every adult who meets the licensed eligibility, health authorities have introduced access in stages, prioritising people with the greatest clinical need first. In practice, that has meant higher BMI thresholds and the presence of several weight-related health conditions for the earliest groups, with the intention of widening the criteria over a period of years as capacity allows.
Access has historically run through specialist weight-management services, which combine medication with dietary, behavioural and sometimes psychological support. More recently, arrangements have begun to involve general practice in some areas, though provision varies considerably from one part of the country to another. Patients who meet the current criteria may still face a wait, and those who meet the licensed eligibility but not the current NHS phase may be told they are not yet able to access the treatment through this route.
The strength of the NHS pathway is the wraparound care. Treatment is free at the point of use, apart from standard prescription charges where they apply, and it sits within a wider programme designed to support long-term change. The limitation is availability. A patient who is clinically eligible under the medicine’s licence may nonetheless find the door closed, or not yet open, in their area.
The private route: online consultation, eligibility checks and patient-funded supply
The private route has grown precisely because of that gap, and with it the number of adults looking to buy Mounjaro online rather than wait. Regulated online pharmacies in the UK can supply Mounjaro to eligible adults after an online clinical consultation with a prescriber. The patient completes a detailed health questionnaire, provides identity verification and, in many cases, photographs or measurements that allow the prescriber to confirm BMI. The prescriber reviews the information, may ask follow-up questions and decides whether the medicine is appropriate. A pharmacist then checks the order before it is dispatched in temperature-controlled packaging.
Eligibility on the private route typically follows the medicine’s licence: adults aged 18 and over with a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure or sleep apnoea. People who intend to Buy mounjaro online through a regulated UK pharmacy should therefore expect to be asked searching questions, and should expect that a prescriber may decline to supply if the answers do not support treatment. A process that asks nothing is not a legitimate one.
The cost of the medicine is borne entirely by the patient. This article does not discuss figures, because prices vary and change, but the principle is straightforward: the private route trades the NHS’s free-at-the-point-of-use model for faster, criteria-based access that the patient funds personally, usually on a monthly basis for as long as treatment continues.
Where the two routes genuinely diverge
Several practical differences emerge once the two pathways are set side by side.
- Who assesses you: On the NHS, assessment is typically by a GP or a specialist weight-management team, often face to face. Privately, it is by a prescriber working remotely through an online consultation, with the option of messaging or calling the pharmacy team afterwards.
- How long it takes: NHS access depends on where the patient sits within the phased criteria and on local capacity. Private access is usually a matter of days once the consultation is approved, subject to stock.
- Who pays: The NHS funds treatment for those who qualify. Private patients pay for every pen.
- Breadth of support: NHS programmes are designed around structured lifestyle support. Private pharmacies vary; some offer dietary guidance and regular check-ins, others provide the medicine with clinical oversight and little else. Patients should ask what is included.
- Continuity: NHS treatment is reviewed within the service. Private treatment requires the patient to complete periodic consultation renewals so that the prescriber can confirm the medicine remains appropriate.
Some patients begin privately while waiting for NHS criteria to widen, then transfer. Others remain private throughout because they value the speed and discretion. There is no single correct answer, and a GP can often advise on what is realistic locally.
What stays the same on both routes
The similarities matter as much as the differences, because they are the safeguards that protect patients.
First, the medicine remains prescription-only. No pharmacy, NHS or private, may supply it without a prescriber’s authorisation, and any website offering to sell it with no consultation is operating outside the law and almost certainly outside the regulated supply chain.
Second, pharmacist oversight is present on both routes. A registered pharmacist reviews the prescription and the order before dispatch, checks for interactions and is available to answer questions about storage, side effects and how to raise concerns.
Third, the medicine itself is identical. Pens are kept in the fridge before first use, patients follow the prescriber’s schedule rather than adjusting anything themselves, and the same side effects, including nausea, digestive upset and reduced appetite among the more common, apply regardless of who dispensed it. Anyone experiencing symptoms that concern them should speak to their prescriber or pharmacist promptly.
Fourth, the regulator is the same. The General Pharmaceutical Council registers every legitimate pharmacy in Great Britain, and its public register allows anyone to check that a pharmacy and its superintendent pharmacist are genuine. Cured Pharmacy, for example, is a UK-registered online pharmacy operating under GPhC registration 9012511 with a superintendent pharmacist on record, and its ordering process requires an online consultation with a prescriber before any supply is made. Patients considering any private provider should look for exactly those markers before entering personal or payment details.
Questions patients are asking before choosing
Pharmacists suggest a handful of questions that help people decide between the two routes. Does the patient currently meet the NHS criteria in their area, and if not, when might they? Can they sustain the private cost for the duration of treatment, bearing in mind that stopping abruptly is something to discuss with a prescriber rather than decide alone? What ongoing support does the private pharmacy actually provide? And, for anyone intending to buy Mounjaro online, is the pharmacy’s GPhC registration number displayed and verifiable?
Patients are also encouraged to tell their GP if they begin private treatment, so that their medical record is complete and any other prescriptions can be reviewed with the new medicine in mind. The two routes are not rivals; for many people they are two stages of the same journey.
Two routes, one standard
The emergence of a private, regulated pathway alongside the NHS has given eligible adults in the UK a genuine choice about how they access Mounjaro. The NHS offers structured, funded care within a phased system; private online pharmacies offer faster, patient-funded access after an online consultation. What both share is the thing that matters most: a prescriber’s decision, a pharmacist’s oversight and a regulated supply chain that patients can verify for themselves. Whichever door a person chooses, those safeguards should be the first thing they look for.
This article is general information, not medical advice.
